The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Funders
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Editorial Policy Advisory Group
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Funders
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
Türk Kardiyoloji Derneği Arşivi
(Oct 2020)
COVID-19 and RAAS blockers: Could Aliskiren be an appropriate option?
Selçuk Şen,
Ali Yağız Üresin
Affiliations
Selçuk Şen
Department of Medical Pharmacology, Division of Clinical Pharmacology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey
Ali Yağız Üresin
Department of Medical Pharmacology, Division of Clinical Pharmacology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey
DOI
https://doi.org/10.5543/tkda.2020.64072
Journal volume & issue
Vol. 48, no. 7
pp. 631 – 634
Abstract
Read online
No abstracts available.
Keywords
covid-19
ace inhibitor
angiotensin receptor blocker
direct renin inhibitor
aliskiren
WeChat QR code
Close